ML216-Induced BLM Helicase Inhibition Sensitizes PCa Cells to the DNA-Crosslinking Agent Cisplatin

Using standard DNA-damaging medicines with DNA repair inhibitors is a promising anticancer tool to achieve better therapeutic responses and reduce therapy-related side effects. Cell viability assay, neutral comet assay, western blotting (WB), and cell cycle and apoptosis analysis were used to determ...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Xiao-Yan, Zhao, Jia-Fu, Ruan, Yong, Zhang, Wang-Ming, Zhang, Lun-Qing, Cai, Zheng-Dong, Xu, Hou-Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788632/
https://www.ncbi.nlm.nih.gov/pubmed/36557923
http://dx.doi.org/10.3390/molecules27248790

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788632/
https://www.ncbi.nlm.nih.gov/pubmed/36557923
http://dx.doi.org/10.3390/molecules27248790

Ejemplares similares